Cargando…

POST-discharge thromboprophylaxis in patients with COVID-19: a single-center experience

Detalles Bibliográficos
Autores principales:	Simion, Chiara, Campello, Elena, Boccatonda, Andrea, Tormene, Daniela, Spiezia, Luca, Dalla Valle, Fabio, Sartori, Marta, Perin, Nicola, Forestan, Chiara, Simioni, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801346/ https://www.ncbi.nlm.nih.gov/pubmed/36583850 http://dx.doi.org/10.1007/s11739-022-03170-y

Ejemplares similares

Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation
por: Poletto, Francesco, et al.
Publicado: (2022)

Persistently High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis
por: Spiezia, Luca, et al.
Publicado: (2023)

Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19
por: Campello, Elena, et al.
Publicado: (2022)

Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study
por: Campello, Elena, et al.
Publicado: (2020)

Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study
por: Campello, Elena, et al.
Publicado: (2022)

Treatment of Refractory/High-Risk Pregnancies With Antiphospholipid Syndrome: A Systematic Review of the Literature
por: Hoxha, Ariela, et al.
Publicado: (2022)

Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute‐on‐chronic liver failure
por: Campello, Elena, et al.
Publicado: (2021)

The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study
por: Tormene, Daniela, et al.
Publicado: (2021)

Potential Association between Distal Deep Vein Thrombosis and Asymptomatic Atherosclerosis
por: Adamo, Angelo, et al.
Publicado: (2021)

More Severe Hypercoagulable State in Acute COVID-19 Pneumonia as Compared With Other Pneumonia
por: Spiezia, Luca, et al.
Publicado: (2020)

WITHDRAWN: More Severe Hypercoagulable State in Acute COVID-19 Pneumonia as Compared to Other Oneumonia
por: Spiezia, Luca, et al.
Publicado: (2021)

Optimal duration of anticoagulation in patients with venous thromboembolism
por: Prandoni, Paolo, et al.
Publicado: (2011)

Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study
por: Campello, Elena, et al.
Publicado: (2021)

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma
por: Zanetto, Alberto, et al.
Publicado: (2018)

How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report
por: Zanon, Ezio, et al.
Publicado: (2020)

Correction to: Acute pulmonary embolism in COVID-19 related hypercoagulability
por: Cerruti, Lorenzo, et al.
Publicado: (2020)

Acute pulmonary embolism in COVID-19 related hypercoagulability
por: Lorenzo, Cerruti, et al.
Publicado: (2020)

Thromboprophylaxis for Patients with High-risk Atrial Fibrillation and Flutter Discharged from the Emergency Department
por: Vinson, David R., et al.
Publicado: (2018)

Just Missing the Mark: Discharging High-risk Atrial Fibrillation / Flutter without Thromboprophylaxis
por: Thompson, Linda B., et al.
Publicado: (2018)

Effectiveness and safety of extended thromboprophylaxis in post-discharge patients with COVID-19: A systematic review and meta-analysis
por: Dai, Meng-Fei, et al.
Publicado: (2023)

MAC Project—Monitoring Anticoagulant Therapy Observational Study: Rationale and Protocol
por: Camporese, Giuseppe, et al.
Publicado: (2021)

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial
por: Ramacciotti, Eduardo, et al.
Publicado: (2022)

Clinical Pharmacology of Factor XI Inhibitors: New Therapeutic Approaches for Prevention of Venous and Arterial Thrombotic Disorders
por: Campello, Elena, et al.
Publicado: (2022)

Efficacy and Safety of Thromboprophylaxis Post-Orthopedic Surgery
por: Alsheikh, Khalid, et al.
Publicado: (2021)

Whole-blood hypocoagulable profile correlates with a greater risk of death within 28 days in patients with severe sepsis
por: Boscolo, Annalisa, et al.
Publicado: (2020)

This Article Corrects: “Just Missing the Mark: Discharging High-risk Atrial Fibrillation/Flutter without Thromboprophylaxis”
por: Thompson, Linda B., et al.
Publicado: (2019)

Platelet-Derived Microparticles Bearing PF4 and Anti-GAGS Immunoglobulins in Patients with Sepsis
por: Sartori, Maria Teresa, et al.
Publicado: (2020)

Thromboprophylaxis in critical care
por: Helms, Julie, et al.
Publicado: (2022)

Thromboprophylaxis in Abdominoplasty: Efficacy and Safety of a Complete Perioperative Protocol
por: Marangi, Giovanni Francesco, et al.
Publicado: (2016)

Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project
por: Bernardi, Enrico, et al.
Publicado: (2022)

Efficacy and safety of direct oral anticoagulants in older adults with atrial fibrillation: a prospective single-centre cohort study
por: Catalani, Filippo, et al.
Publicado: (2023)

Obstetric Thromboprophylaxis: The Swedish Guidelines
por: Lindqvist, Pelle G., et al.
Publicado: (2011)

Pharmacological thromboprophylaxis and epidural anaesthesia
por: Harsoor, SS, et al.
Publicado: (2012)

Thromboprophylaxis in routine arthroscopy of knee
por: Abouali, Jihad, et al.
Publicado: (2013)

Thromboprophylaxis for Total Knee Arthroplasty
por: Gali, Julio Cesar, et al.
Publicado: (2019)

Thromboprophylaxis after bariatric surgery
por: Almarshad, Feras M., et al.
Publicado: (2020)

Venous Thromboprophylaxis in Spine Surgery
por: Alvarado, Anthony M., et al.
Publicado: (2019)

Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project
por: Bortoluzzi, Cristiano, et al.
Publicado: (2022)

More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC
por: Zanetto, Alberto, et al.
Publicado: (2021)

Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence
por: Ferguson, Caleb, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qo5i95u887tsah5e7a9rj62fbp